Friday, May 26, 2006

Choosing Chemotherapy

Choosing Chemotherapy for Her2 Positive Cancer

We've described the combination of chemotherapy chosen for Marjory elsewhere on this site

The way that the Edinburgh Cancer Centre and the Edinburgh Breast Unit work is to have a once weekly multi-disciplinary meeting of all the medical, nursing and other related teams. This meeting discusses each patient in turn and a consensus is reached on the best combination of treatments for each patient.

Marjory was allocated this combination:

  • Four sessions of CEF chemotherapy at three week intervals
  • Four weeks of radiotherapy
  • Four sessions of Taxotere and Herceptin
  • Ongoing Herceptin
  • Femara for long term
Reading this article about modern treatment concepts for HER2 positive tumours suggests that her treatment plan is following pretty much the most cutting edge option.
This of course is both encouraging and scary at the same time - so on we go. Wish us luck!
Gordon

0 comments: